• BAY-826 for Reliable Retinal Viability Assays

  2026-08-12

  This scenario-based guide explains how BAY-826 (SKU BA8899) can support controlled biochemical and cellular studies involving angiogenesis-related signaling and retinal neuron survival. It covers assay interpretation, co-culture compatibility, dilution strategy, storage, and practical vendor-selection criteria without conflating a reported biochemical IC50 with a universal cellular response.

• Dihydroartemisinin: Mechanism and Research Use

  2026-08-12

  Dihydroartemisinin is a peroxide-containing Artemisia-derived compound used in antimalarial, inflammation, psoriasis, and cell-signaling research. Its reported mTOR-pathway activity is model-specific, while its formula, solvent compatibility, storage requirements, and quality specifications are defined on the product page.

• EPZ5676: A Practical DOT1L Inhibitor Workflow

  2026-08-11

  EPZ5676 combines subnanomolar biochemical potency with exceptional selectivity, making it useful for connecting DOT1L activity to H3K79 methylation, MLL-fusion gene expression, and leukemia-cell phenotypes. This guide outlines an integrated workflow for enzyme assays, chromatin validation, acute leukemia cell line cytotoxicity, and troubleshooting solvent, timing, and assay-specific failure points.

• Biotin-HPDP Workflows for Reversible Thiol Labeling

  2026-08-11

  Biotin-HPDP enables selective, cleavable labeling of protein thiols for affinity capture, redox analysis, and S-nitrosylation workflows. This guide translates recent PPT1 neurobiology findings into practical assay designs while emphasizing solvent handling, control logic, and troubleshooting.

• 2'3'-cGAMP/Rab18/FosB and Cell Migration

  2026-08-10

  Deng et al. identify Rab18 as a previously unrecognized 2'3'-cGAMP binding partner that connects this cyclic dinucleotide to FosB-dependent cell migration independently of canonical innate-immune signaling. The work expands the functional scope of the cGAS-STING signaling pathway and provides a framework for separating STING-mediated innate immune response from noncanonical cGAMP biology.

• Cefazedone (Refosporen): From PBP Biology to Translation

  2026-08-09

  A translational framework for positioning Cefazedone (Refosporen) in antibacterial research, connecting penicillin-binding protein biology, resistant staphylococcal models, assay design, and pharmacodynamic interpretation.

• Idoxuridine: Mechanism-First Antiviral Assay Design

  2026-08-08

  Idoxuridine, also known as 5-iodo-2'-deoxyuridine, is a research-use nucleoside analog for investigating viral DNA synthesis inhibition. This article provides a mechanism-first framework for separating DNA replication disruption from cytotoxicity and shows how insights from human-neuron pharmacology can sharpen assay interpretation without overstating cross-domain evidence.

• Deferasirox Fe3+ Chelate in Iron Research

  2026-08-07

  Build reproducible ferric-iron assays with a defined, DMSO-soluble Deferasirox Fe3+ chelate preparation. This practical guide connects Exjade-related clinical pharmacology with cell-free binding tests, chronic anemia iron management models, and troubleshooting strategies for precomplexed iron-chelator workflows.

• Amplex Red: Advancing Oxidative Stress and Redox Assays

  2026-08-07

  Amplex Red (10-Acetyl-3,7-dihydroxyphenoxazine) unlocks ultrasensitive, quantitative hydrogen peroxide and peroxidase activity detection, empowering precise oxidative stress monitoring across basic and translational research. Its performance, adaptability, and troubleshooting flexibility set a new benchmark for redox biology and high-throughput screening workflows.

• Light-Inducible RNA Control for Precision Gene Therapy Regul

  2026-08-06

  The referenced study presents a rationally engineered light-inducible RNA-releasing protein (LIRP) that enables spatiotemporal, reversible control of gene expression at the translational level in vivo. This innovation allows for precise, on-demand regulation of therapeutic transgenes, with demonstrated applications in metabolic and retinal disease models, marking a significant advance in optogenetic gene therapy safety and flexibility.

• Rimonabant (SR141716): Applied Protocols for Appetite and Pa

  2026-08-06

  Leverage Rimonabant (SR141716) from APExBIO to dissect CB1-mediated pathways in appetite regulation, neurobiology, and inflammation. This guide details high-specificity protocols, actionable troubleshooting strategies, and the practical impact of mechanistic discoveries on experimental design.

• Photothermal Therapy Enhances CD47 Blockade in OSCC via Calr

  2026-08-05

  This study demonstrates that photothermal therapy (PTT) synergizes with CD47 blockade to enhance macrophage-mediated clearance in oral squamous cell carcinoma (OSCC) by promoting calreticulin exposure and remodeling the extracellular matrix. The findings highlight a dual mechanism enabling both improved immune recognition and macrophage infiltration, offering a technically robust approach to overcoming immune evasion in solid tumors.

• Potassium Iodide in Immuno-Oncology: Mechanisms, Stability,

  2026-08-05

  Discover how Potassium Iodide (KI) advances immuno-oncology research through its pivotal role in thyroid hormone synthesis and radioprotection. This article delivers a deeper technical analysis, protocol guidance, and critical insights into intelligent delivery systems for KI.

• T-5224: Precision AP-1 Inhibition for Translational Inflamma

  2026-08-04

  This article explores the mechanistic and translational impact of T-5224, a selective C-Fos/AP-1 inhibitor, for researchers targeting neuroinflammatory and arthritic disease mechanisms. It bridges recent discoveries in mechanosensory neuroinflammation and AP-1 signaling, providing actionable guidance for experimental design and future directions.

• MK-571 (L-660,711): Illuminating Immune Cell Protection Path

  2026-08-04

  Explore how MK-571 (L-660,711) advances leukotriene-mediated inflammation research and reveals new mechanistic insights into immune cell protection during chemotherapy. This deep dive uniquely connects receptor antagonism with multidrug resistance modulation.

16254 records 1/1084 page Next 12345 下5页 Last page